The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)


PCR London Valves Innovators Day 2017. Where will valve intervention be in 2025?

EuroIntervention 2017;13:1140-1143. DOI: 10.4244/EIJV13I10A178

1. Cedars Sinai Medical Center, Los Angeles, USA, and University of Oxford, Oxford, United Kingdom; 2. Centre Hospitalier Regional Universitaire de Lille, Lille, France; 3. Bern University Hospital, Bern, Switzerland; 4. McGill University Health Hospital,

Innovators Day at PCR London Valves 2017 brought together over 300 key stakeholders in the future of transcatheter valve therapies for a day of discussion, networking and reflection. Venture capitalists, economists, industry leaders, scientists, engineers, clinical trialists and clinicians all featured in a programme of teaching, small group discussion and debate to provide perspectives on unresolved issues in the field and predict developments by 2025. A key feature of the innovative programme was a one-hour round table workshop in which participants contributed to small multidisciplinary group discussions facilitated by key opinion leaders (Figure 1) addressing the immediate future of percutaneous valve intervention. Collation ...

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

Read next article
Contemporary considerations in left main stem treatment